Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002181 |
---|---|
Receipt number | R000001829 |
Scientific Title | A phase II study to confirm the feasibility of S-1 plus CPT-11 as a post operative chemotherapy for the patients with advanced gastric cancer in stage IIIA and IIIB (OGSG 0801) |
Date of disclosure of the study information | 2009/07/10 |
Last modified on | 2022/11/06 14:17:33 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/07/10 16:32:23 | ||
2 | Update | 2009/12/04 17:43:48 | Recruitment status |
|
3 | Update | 2011/02/24 15:56:07 | Recruitment status Last follow-up date |
|
4 | Update | 2012/06/24 23:48:12 | Public title Public title Acronym Acronym |
|
5 | Update | 2012/06/24 23:53:22 | Last name of contact person Last name of contact person Name of person sending information Organization Organization Division name Address Address TEL Post marketing survey by drug manufacture etc., specified by Japanese law. Organization1 Address1 Tel1 Email1 |
|
6 | Update | 2013/01/10 20:29:43 | Last follow-up date |
|
7 | Update | 2013/07/10 09:58:01 | Anticipated trial start date |
|
8 | Update | 2014/02/10 12:58:20 | Recruitment status |
|
9 | Update | 2022/11/06 13:46:56 | Recruitment status Date of IRB |
|
10 | Update | 2022/11/06 14:11:47 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
11 | Update | 2022/11/06 14:17:33 | Recruitment status |